476 related articles for article (PubMed ID: 24028755)
21. An evaluation of the clinical and cost-effectiveness of pulmonary artery catheters in patient management in intensive care: a systematic review and a randomised controlled trial.
Harvey S; Stevens K; Harrison D; Young D; Brampton W; McCabe C; Singer M; Rowan K
Health Technol Assess; 2006 Aug; 10(29):iii-iv, ix-xi, 1-133. PubMed ID: 16904048
[TBL] [Abstract][Full Text] [Related]
22. Preoperative intravenous iron for anaemia in elective major open abdominal surgery: the PREVENTT RCT.
Richards T; Baikady RR; Clevenger B; Butcher A; Abeysiri S; Chau M; Swinson R; Collier T; Dodd M; Dyck LV; Macdougall I; Murphy G; Browne J; Bradbury A; Klein A
Health Technol Assess; 2021 Feb; 25(11):1-58. PubMed ID: 33632377
[TBL] [Abstract][Full Text] [Related]
23. Prehospital continuous positive airway pressure for acute respiratory failure: the ACUTE feasibility RCT.
Fuller GW; Keating S; Goodacre S; Herbert E; Perkins GD; Rosser A; Gunson I; Miller J; Ward M; Bradburn M; Thokala P; Harris T; Marsh MM; Scott AJ; Cooper C
Health Technol Assess; 2021 Feb; 25(7):1-92. PubMed ID: 33538686
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
Santhakumaran S; Gordon A; Prevost AT; O'Kane C; McAuley DF; Shankar-Hari M
Crit Care; 2019 May; 23(1):156. PubMed ID: 31053084
[TBL] [Abstract][Full Text] [Related]
25. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.
Matthay MA; Calfee CS; Zhuo H; Thompson BT; Wilson JG; Levitt JE; Rogers AJ; Gotts JE; Wiener-Kronish JP; Bajwa EK; Donahoe MP; McVerry BJ; Ortiz LA; Exline M; Christman JW; Abbott J; Delucchi KL; Caballero L; McMillan M; McKenna DH; Liu KD
Lancet Respir Med; 2019 Feb; 7(2):154-162. PubMed ID: 30455077
[TBL] [Abstract][Full Text] [Related]
26. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial.
Bellingan G; Brealey D; Mancebo J; Mercat A; Patroniti N; Pettilä V; Quintel M; Vincent JL; Maksimow M; Jalkanen M; Piippo I; Ranieri VM
Trials; 2017 Nov; 18(1):536. PubMed ID: 29132404
[TBL] [Abstract][Full Text] [Related]
28. Impact of distinct definitions of acute lung injury on its incidence and outcomes in Brazilian ICUs: prospective evaluation of 7,133 patients*.
Caser EB; Zandonade E; Pereira E; Gama AM; Barbas CS
Crit Care Med; 2014 Mar; 42(3):574-82. PubMed ID: 24158166
[TBL] [Abstract][Full Text] [Related]
29. Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome.
Drago BB; Kimura D; Rovnaghi CR; Schwingshackl A; Rayburn M; Meduri GU; Anand KJ
Pediatr Crit Care Med; 2015 Mar; 16(3):e74-81. PubMed ID: 25634565
[TBL] [Abstract][Full Text] [Related]
30. Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in acute lung injury to reduce pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial.
McAuley DF; Laffey JG; O'Kane CM; Cross M; Perkins GD; Murphy L; McNally C; Crealey G; Stevenson M; ;
Trials; 2012 Sep; 13():170. PubMed ID: 22985805
[TBL] [Abstract][Full Text] [Related]
31. Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury.
Manocha S; Gordon AC; Salehifar E; Groshaus H; Walley KR; Russell JA
Crit Care; 2006 Feb; 10(1):R12. PubMed ID: 16420663
[TBL] [Abstract][Full Text] [Related]
32. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
[TBL] [Abstract][Full Text] [Related]
33. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J
Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491
[TBL] [Abstract][Full Text] [Related]
34. High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome.
Santa Cruz R; Rojas JI; Nervi R; Heredia R; Ciapponi A
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009098. PubMed ID: 23740697
[TBL] [Abstract][Full Text] [Related]
35. Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR).
Peek GJ; Elbourne D; Mugford M; Tiruvoipati R; Wilson A; Allen E; Clemens F; Firmin R; Hardy P; Hibbert C; Jones N; Killer H; Thalanany M; Truesdale A
Health Technol Assess; 2010 Jul; 14(35):1-46. PubMed ID: 20642916
[TBL] [Abstract][Full Text] [Related]
36. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
37. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.
Haeberle H; Prohaska S; Martus P; Straub A; Zarbock A; Marx G; Zago M; Giera M; Koeppen M; Rosenberger P
Trials; 2020 Mar; 21(1):242. PubMed ID: 32131881
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.
Bellani G; Laffey JG; Pham T; Fan E; Brochard L; Esteban A; Gattinoni L; van Haren F; Larsson A; McAuley DF; Ranieri M; Rubenfeld G; Thompson BT; Wrigge H; Slutsky AS; Pesenti A; ;
JAMA; 2016 Feb; 315(8):788-800. PubMed ID: 26903337
[TBL] [Abstract][Full Text] [Related]
40. Model-based PEEP titration versus standard practice in mechanical ventilation: a randomised controlled trial.
Kim KT; Morton S; Howe S; Chiew YS; Knopp JL; Docherty P; Pretty C; Desaive T; Benyo B; Szlavecz A; Moeller K; Shaw GM; Chase JG
Trials; 2020 Feb; 21(1):130. PubMed ID: 32007099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
